Related by context. All words. (Click for frequent words.) 61 dyspnoea 59 posttreatment 58 renal allograft 58 multivariable analyzes 58 postintervention 58 hepatorenal syndrome 57 CR nPR 57 subscale scores 56 CORE OM 56 angiographically 56 interrater reliability 56 antibody titer 56 femoral neck fracture 56 NYHA functional class 56 Severe Acute Malnutrition 56 seropositivity 56 HSCT 56 postoperative complication 56 elevated ALT 56 lymphocytosis 56 CR CRu 56 bivariate analysis 55 underwent resection 55 pCR 55 CCyR 55 Main Outcome Measure 55 intraobserver 55 mediastinitis 55 clinicopathological features 55 atrioventricular block 55 BEXXAR Therapeutic Regimen 55 pelvic lymph node dissection 55 BPS IC 55 RBC transfusion 55 PCWP 55 lung resection 55 Brief Psychiatric 55 renal biopsy 55 undetectable HBV DNA 55 pretransplant 55 squamous intraepithelial lesions 55 parasitological 55 renal cysts 54 locoregional 54 cranial irradiation 54 intrapartum 54 autonomic dysfunction 54 Primary endpoints 54 Echocardiographic 54 potent antiretroviral therapy 54 clinicopathological 54 NIHSS 54 biochemical relapse 54 ultrasonographic 54 AST ALT 54 cecal intubation 54 evaluable subjects 54 PSA nadir 54 tracheal intubation 54 computed tomographic scan 54 R0 resection 54 CSBM 54 Coronary artery bypass grafting 54 locoregional disease 54 Injury Severity Score 54 Thrombolysis 54 NNT = 54 DAS# remission 54 remission CR 53 univariate analysis 53 HRQL 53 IPAH 53 TURBT 53 glucocorticoid induced 53 genotypic resistance 53 Kaplan Meier analysis 53 Cardiopulmonary bypass 53 chorioamnionitis 53 neurocognitive outcomes 53 EDSS score 53 thymoma 53 myocardial ischaemia 53 hemodynamically stable 53 % CI #.#-#.# [007] 53 esophageal carcinoma 53 DAS# CRP 53 HBeAg seroconversion 53 rapid virological response 53 % CI #.#-#.# [003] 53 Univariate analysis 53 prospective multicenter study 53 plasma pharmacokinetics 53 NMIBC 53 interferon γ 53 postexposure prophylaxis 53 sustained virological response 53 multivariable analysis 53 NIHSS score 53 histologically confirmed 52 IntroductionThe 52 gastroduodenal 52 RARP 52 NSQIP 52 LRTI 52 RECIST criteria 52 intact parathyroid hormone 52 FluCAM arm 52 histopathological 52 prostate cancer CaP 52 euthyroid 52 BSIs 52 hip resurfacing arthroplasty 52 Preoperative 52 chest radiographs 52 colonoscopic 52 spirometric 52 RENAL 52 postoperative chemotherapy 52 intracranial hemorrhage ICH 52 TKAs 52 prospectively stratified 52 venous thromboembolic disease 52 RECIST Response Evaluation Criteria 52 hematologic parameters 52 percutaneous vertebroplasty 52 atherothrombotic 52 pT2 52 elevated transaminases 52 Histological 52 TNM staging 52 OPCAB 52 myocardial necrosis 52 Partial Response 52 5-fluorouracil/leucovorin 52 preoperative diagnosis 52 nodal metastasis 52 semistructured interview 52 postpartum hemorrhage 52 Index CDAI 52 hippocampal atrophy 52 prospectively defined 52 preoperative PSA 52 transvaginal sonography 52 thromboprophylaxis 52 Logistic regression analysis 52 Global Impression CGI 52 diabetes mellitus DM 52 multivariate analyzes 52 RECIST 51 PASI scores 51 prognostic significance 51 urinary albumin excretion 51 relapsed MM 51 scintigraphic 51 CDAI 51 patients evaluable 51 distal radial fractures 51 â ‰ ¥ 51 GH deficiency 51 transrectal ultrasound guided 51 dosage regimens 51 Visual Analogue Scale VAS 51 demyelinating 51 IOP lowering 51 preterm neonates 51 receptor antagonism 51 EuroSCORE 51 intestinal metaplasia 51 pacemaker implantation 51 ventilatory 51 Lymphocytic 51 Arch Intern Med 51 tipranavir r 51 submucosal 51 allogeneic transplant 51 prognostic variables 51 de novo AML 51 Main Outcome Measures 51 Catheter Associated 51 suboptimal adherence 51 fibrinolytic therapy 51 CRp 51 parasitaemia 51 chemoradiation therapy 51 Secondary endpoints include 51 perfusion abnormalities 51 aminotransferase 51 unicompartmental knee arthroplasty 51 LV ejection fraction 51 resected pancreatic cancer 51 MMSE score 51 clinically meaningful improvement 51 F FDG PET 51 myocardial viability 51 polyarticular 51 ACR# response 51 urodynamic parameters 51 vasoactive 51 Postoperative complications 51 MS DRG 51 ACEI 51 SGRQ 51 mRS 51 nonadherence 51 premorbid 51 Multivariate analysis 51 PHPT 51 Adjuvant therapy 51 primary percutaneous coronary 51 Acute Decompensated Heart Failure 51 histopathologic diagnosis 51 transthoracic echocardiography 51 nephron sparing surgery 51 somatostatin analog 51 endoscopic resection 51 haematologic 51 digital subtraction angiography 51 cystoscopic 51 lymph node metastasis 51 detectable HCV RNA 50 CTEPH 50 viral kinetics 50 poststroke 50 lymphocyte count 50 intravascular hemolysis 50 papillary thyroid carcinoma 50 subscore 50 mucosal inflammation 50 intravesical therapy 50 HADS 50 liver transplantations 50 MDRD 50 gastric adenocarcinoma 50 ovarian malignancy 50 advanced adenoma 50 histopathologic examination 50 CSF biomarkers 50 Surviving Sepsis Campaign 50 undetectable HCV RNA 50 HER2 expression 50 interobserver 50 symptomatic DVT 50 hematological parameters 50 virologic suppression 50 perinatal mortality 50 enthesitis 50 lymphovascular invasion 50 achieved CCyR 50 -#.# ± [002] 50 aortic root replacement 50 transcranial Doppler ultrasound 50 radical prostatectomy RP 50 virological suppression 50 acute humoral rejection 50 hypophosphatemia 50 chest radiography 50 clinico pathological 50 seroprotection 50 pharmacodynamic PD 50 Retreatment 50 Stage IIIA 50 multicentre prospective 50 Hemodynamic 50 independent prognostic marker 50 randomized controlled trials RCTs 50 % CI #.#-#.# [008] 50 pancreatectomy 50 FDG PET imaging 50 antibiotic regimens 50 Acute Physiology 50 allogeneic hematopoietic stem cell 50 myocardial revascularization 50 endometrial biopsies 50 neurologic impairment 50 HOMA IR 50 histologically proven 50 interstitial brachytherapy 50 Common Toxicity Criteria 50 HDRS 50 ventilation perfusion 50 cytologic 50 HIV seropositive 50 covariate 50 multivariate Cox 50 HPV-#/# 50 IRLS 50 P = .# 50 clinically asymptomatic 50 clinicopathologic 50 ejection fractions 50 extrapleural pneumonectomy 50 pathologic examination 50 oncologic outcomes 50 urothelial carcinoma 50 immunosuppression therapy 50 antimicrobial prophylaxis 50 ECLS 50 elevated IOP 50 TRUS 50 Fontan procedure 50 RTOG 50 electrophysiologic 50 malignant neoplasms 50 patientswith 50 PPCM 50 Ann Emerg Med 49 p = #.# [003] 49 Histologic 49 ACCF AHA 49 VATS lobectomy 49 Cardiorespiratory fitness 49 somatosensory evoked potentials 49 TIMP 1 49 Acute renal failure 49 atherosclerotic lesion 49 microbiologically evaluable 49 preemptive analgesia 49 F FLT 49 Lumbar spine 49 preserved LVEF 49 Kaplan Meier estimates 49 cTnI 49 Langerhans cell histiocytosis 49 neutropenic patients 49 radical nephrectomy 49 adenotonsillectomy 49 erection hardness 49 NYHA 49 diabetic polyneuropathy 49 Myocardial 49 methacholine challenge 49 Lymph node 49 histological subtype 49 antiretroviral naïve 49 immunotoxicity 49 iPTH 49 HbA 1c levels 49 oral anticoagulation 49 Severity Index PASI 49 Complete Response CR 49 comorbid anxiety 49 Patency 49 moderately emetogenic 49 BPH LUTS 49 TIMP 49 MS DRGs 49 CIMZIA TM 49 ALSFRS R 49 NEAP 49 TMC# r 49 MBq 49 leiomyomas 49 CIN2 + 49 pulmonary exacerbation 49 poststroke depression 49 HGPIN 49 VTE prophylaxis 49 total thyroidectomy 49 renal tumors 49 TB MDR TB 49 myocardial dysfunction 49 hydronephrosis 49 NICE guideline 49 Programme RNTCP 49 somatization disorder 49 MCID 49 biochemical recurrence 49 stratifying patients 49 ACR Pedi 49 Tumor Response 49 ECOG PS 49 Secondary efficacy endpoints 49 CFQ R 49 Viral load 49 albumin excretion 49 Radiographic 49 surgical debulking 49 gastric carcinoma 49 CsA 49 epithelial ovarian cancer 49 logistic regression model 49 mesalamine granules 49 histologic subtype 49 meta regression 49 logistic regression models 49 mg/m2 dose 49 BPRS 49 Symptom Checklist 49 immunostaining 49 neuropathologic 49 eculizumab therapy 49 radicular pain 49 Acute Myeloid Leukaemia AML 49 Kaplan Meier method 49 bone scintigraphy 49 NSABP B 49 confounder 49 QTc intervals 49 von Willebrand 49 urethral stricture 49 perfusion defects 49 severe exacerbations 49 psychiatric comorbidity 49 Hypertrophic 49 Cardio vascular 49 interferon ribavirin 49 Ebstein anomaly 49 endoscopic retrograde cholangiopancreatography ERCGrant Parpan 49 allogeneic bone marrow 49 pDC 49 troponin T 48 certolizumab 48 Intravenous Infusion 48 sensory neuropathy 48 observational cohort 48 HAQ DI 48 DSM IV diagnoses 48 psychiatric outpatients 48 serum PTH 48 colorectal adenocarcinoma 48 Intubation 48 HBeAg negative patients 48 methotrexate monotherapy 48 = #.#-#.# 48 syndromic 48 euthymic patients 48 coxsackievirus 48 Sociodemographic 48 symptomatic intracranial hemorrhage 48 Cystatin C 48 NNRTI resistance 48 Preoperatively 48 retrospective cohort study 48 laparoscopic partial nephrectomy 48 Rate ORR 48 peripartum 48 transurethral 48 Percutaneous Coronary Interventions 48 multivariate logistic regression 48 Multivariate logistic regression 48 multivariate adjustment 48 TEVAR 48 serum calcium levels 48 abnormal cytology 48 univariate 48 thyroglobulin 48 evaluable 48 Current Controlled Trials 48 pathologic diagnosis 48 predictive validity 48 seminal vesicle invasion 48 silent myocardial ischemia 48 viremia 48 Doppler sonography 48 confidence intervals CIs 48 Skin sterol 48 ALS Functional 48 intravenous diuretics 48 creatinine ratio 48 Timed Walk 48 IL#B 48 virologic 48 anti Xa 48 adnexal mass 48 transabdominal 48 parenteral antibiotics 48 J Immunol 48 exploratory endpoints 48 PSQI 48 biopsy Gleason 48 QRS duration 48 ICD shocks 48 antibiotic prophylaxis 48 ACR# responses 48 cardiac perfusion 48 dosimetric 48 multivariate regression analysis 48 virologic response 48 Radical prostatectomy 48 degenerative lumbar 48 risk reducing salpingo 48 CIBIC Plus 48 StAR 48 eosinophil count 48 % CI #.#-#.# [001] 48 Hb A1c 48 EPDS 48 Negative Symptoms 48 invasive carcinomas 48 bronchopulmonary 48 transthoracic 48 C difficile infection 48 pretreatment serum 48 neoadjuvant treatment 48 surrogate markers 48 intraabdominal 48 Zevalin consolidation 48 intraepithelial neoplasia 48 ACC AHA 48 psychiatric inpatients 48 demonstrated clinically meaningful 48 Pharmacokinetic parameters 48 Non inferiority 48 Arterial Hypertension 48 Adenomas 48 fosbretabulin 48 urolithiasis 47 achieved ACR# 47 CPAP adherence 47 Cronbach alpha 47 astrocytomas 47 BCIRG 47 dyskinetic 47 UPDRS 47 CT urography 47 myocardial blush 47 mitral annular 47 Rheumatic Heart 47 Disease GOLD 47 HRQoL 47 SF #v# 47 hepatocellular carcinomas 47 Chronic Obstructive Lung 47 semiquantitative 47 TRUS biopsy 47 eNO 47 hemagglutination inhibition 47 esophageal varices 47 chemoradiotherapy 47 Histological analysis 47 BFHI 47 intraclass correlation coefficients 47 HbA 1c 47 histopathologic 47 cervical carcinoma 47 cardiologic 47 prothrombotic 47 Pelvic Organ Prolapse 47 Interrater reliability 47 afterload 47 pneumococcal vaccination 47 Operative mortality 47 pathologic fractures 47 sequela 47 % CI #.#-#.# [005] 47 Pneumococcal vaccination 47 tubular atrophy 47 stress echocardiography 47 florbetaben 47 K DOQI 47 ImmuKnow assay 47 microsatellite instability 47 psychometric properties 47 preoperative MRI 47 pT3 47 urine albumin 47 C. trachomatis 47 radical cystectomy 47 vasogenic edema 47 bacillus Calmette Guerin 47 HbA1C levels 47 Adult Cardiac Surgery 47 smoldering multiple myeloma 47 dyssynchrony 47 Uterine Artery Embolization 47 PROCHYMAL 47 AMAF 47 oral prednisolone 47 ASIA Impairment 47 histologic findings 47 sub maximal 47 ICSs 47 complete cytogenetic 47 EDSP 47 NICE SUGAR 47 pulmonary exacerbations 47 echocardiographic parameters 47 LVNC 47 hypofractionated 47 T1a 47 interrater 47 Cervical Cytology 47 CCEVS 47 BCG vaccination 47 viral etiology 47 dose proportionality 47 VLBW infants 47 μg liter 47 Patellofemoral 47 lateral radiographs 47 IIIA NSCLC 47 hemoglobin hematocrit 47 Reperfusion 47 preoperative chemotherapy 47 HYVET 47 euthymic 47 Dacogen decitabine 47 Infarct 47 serogroup C 47 hypercapnia 47 TRAS 47 KRAS status 47 IPSS 47 Transthyretin 47 seroprevalence 47 rho = 47 Comorbidity 47 experienced virologic failure 47 prostate carcinoma 47 pediatric acute lymphoblastic 47 metastatic malignant 47 ANRS 47 baseline HbA1c 47 karyotypes 47 FDG-PET/CT 47 biliary tract cancer 47 multivariable adjusted 47 J Clin Oncol 47 Meta analyzes 47 clinically evaluable patients 47 KDOQI 47 Endometrial 47 experimental allergic encephalomyelitis 47 laparoscopically assisted 47 mesilate 47 null mice 47 trials RCTs 47 SLN biopsy 47 Electroencephalography 47 Oesophageal 47 papillary renal cell carcinoma 47 papillary carcinoma 47 Cancer Res 47 DAS# [002] 47 ALT AST 47 Psoriasis Area 47 PABC 46 darunavir r 46 chemosensitivity 46 Outcome Measures 46 EQ 5D 46 substance induced psychosis 46 oncological outcomes 46 intraclass correlation coefficient 46 histologic diagnosis 46 Vascular Annual Meeting 46 Natalizumab 46 adjuvant cisplatin 46 Angiogram 46 hemodynamic parameters 46 myocardial perfusion 46 pulmonary hypertension PH 46 PCI percutaneous coronary 46 Renal dysfunction 46 lymphoid malignancies 46 HER2 overexpression 46 Histopathology 46 DIABECELL ® 46 convergent validity 46 glycemia 46 thromboembolic disease 46 foveal thickness 46 RCTs 46 Hepatitis B vaccination 46 HCV replicon 46 Rating Scale BPRS 46 IIIb 46 mITT population 46 plasma renin activity 46 sonographically 46 GPRD 46 protease inhibitor PI 46 ELBW 46 Lower Limb 46 bioavailable testosterone 46 prognostic indicators 46 TMPRSS2 ERG fusion 46 Posttraumatic stress disorder 46 urothelial 46 extracapsular extension 46 immunological responses 46 HRQOL 46 RNTCP 46 Lung Injury 46 HbA 1C 46 carotid artery stent 46 attain statistical significance 46 adjuvant systemic 46 CLABSI 46 ADAS cog 46 Histopathologic 46 Iron Overload 46 Multivariate analyzes 46 smoldering myeloma 46 ACTEMRA TM 46 cGy 46 ILLUSTRATE 46 intracardiac 46 nodal dissection 46 IIEF 46 somatoform disorders 46 HBeAg + 46 voiding dysfunction 46 Prognostic factors 46 surgically resected 46 Eur Urol 46 cardiac allograft vasculopathy 46 achieved sustained virological 46 Angiographic 46 tumorigenicity 46 Kellgren Lawrence 46 Peripheral Arterial 46 HLA A2 46 ALT elevation 46 anthracycline containing 46 Cytogenetic 46 nephrectomies 46 Pharmacodynamic 46 PANSS scores 46 troponins 46 guideline concordant 46 pegylated IFN 46 cerebral oxygen saturation 46 external beam radiotherapy 46 multiple linear regression 46 Solid Tumours 46 renal cell carcinomas 46 low expressors 46 dexamethasone suppression 46 liver transaminases 46 Stenting Trial CREST 46 patient centeredness 46 empirically validated 46 glycated hemoglobin 46 pathophysiological mechanisms 46 Perinatal Mortality 46 SIMPADICO 46 serum phosphate levels 46 metastatic bladder 46 sustained virologic response 46 neoadjuvant radiation 46 adenomatous 46 RE LY ® 46 dual antiplatelet 46 pharmacokinetic characteristics 46 metabolite concentrations 46 BILAG 46 Arch Facial Plast 46 opioid naïve 46 ASCUS 46 HIV seroprevalence 46 ECOG 46 HICS 46 Neonates 45 serum biomarker 45 subscales 45 biventricular 45 PLND 45 nitrofurantoin 45 fetal echocardiogram 45 HSSP 45 concomitant AEDs 45 reactive hyperemia 45 pelvic ultrasound 45 abacavir lamivudine 45 Allogeneic 45 neuropsychological assessment 45 immunosuppressive regimen 45 arteriovenous fistulas 45 laparoscopic nephrectomy 45 AJCC 45 Competent Persons Report 45 Prehospital 45 bioprosthetic valve 45 A1c levels 45 RVOT 45 Fully Covered Stent 45 serological tests 45 prospective observational cohort 45 clinically meaningful improvements 45 Free Survival PFS 45 neurocognitive impairment 45 Acute MI 45 Incontinence Impact Questionnaire 45 follicular lymphoma FL 45 HGD 45 Poisson regression 45 mortality morbidity 45 allogeneic transplants 45 MVA MUC1 IL2 45 peritoneal carcinomatosis 45 CALGB 45 HepC 45 FDG PET scans 45 bronchial epithelial cells 45 biodistribution studies 45 Singh Manoux 45 creatine kinase CK 45 cystoid macular edema 45 CYP #D# 45 Visual acuity 45 Quality Indicators 45 micrometastasis 45 inhospital mortality 45 FACIT Fatigue 45 FOLFIRINOX 45 nonparametric 45 syncopal episodes 45 HIPEC 45 T1D 45 Estrogen Receptor 45 myeloproliferative 45 Kidney Disease Outcomes 45 Familial Hypercholesterolemia 45 Maternal Mortality Ratio 45 erythrocyte 45 neutrophil counts 45 NOPR 45 immune dysregulation 45 maximal tolerated 45 Myoglobin 45 bone marrow fibrosis 45 subspecialty certification 45 thromboemboli 45 Hazard Ratio 45 ABL1 45 spondyloarthritis 45 Degenerative Disc Disease 45 Severe Primary IGFD 45 methodologic 45 hemodynamic measurements 45 Histopathological 45 serum alkaline phosphatase 45 genitourinary cancers 45 myeloproliferative diseases 45 vulvovaginal candidiasis 45 MDGS 45 Prolapse 45 TAXUS ARRIVE 45 Systemic Sclerosis 45 cluster randomized controlled 45 Kruskal Wallis test 45 CGIC 45 metabolic dysregulation 45 polysomnographic 45 ICAEL 45 ACR# [002] 45 Aortic Dissection 45 CLL SLL 45 cardiovascular calcification 45 Left Ventricular 45 chromosome #p# [002] 45 CRRT 45 Crit Care 45 Osteoporos Int 45 complement inhibitor eculizumab 45 endometrial adenocarcinoma 45 acute myocardial ischemia 45 statistically significant p = 45 visceral leishmaniasis VL 45 Add.1 45 Health Assessment Questionnaire 45 Systemic Lupus Erythematosus SLE 45 Stage IIIb 45 serum leptin 45 Acute Respiratory 45 intrahepatic cholangiocarcinoma 45 cardiac autonomic 45 allelic variation 45 hemoglobin A1c levels 45 MitraClip device 45 pegylated interferon alfa 2b 45 APBD 45 Randomized clinical trials 45 Clinical Outcome 45 intravenous cyclophosphamide 45 pegIFN 45 hypometabolism 45 Elitek 45 overactive bladder syndrome 45 NTx ® -# 45 BRSV 45 Prognostic Index 45 T1c 45 subcutaneous immunoglobulin 45 cervical lymph node 45 BALF 45 scintigraphy 45 tipranavir ritonavir 45 INSARAG 45 thyroid carcinoma 45 biliary stones 44 glutamate glutamine 44 J Rheumatol 44 multivariable Cox 44 PITX2 methylation 44 hyperhomocysteinemia 44 Selten 44 psychoeducation 44 ER CHOP 44 skeletally mature patients 44 electrograms 44 Clin Pharmacol Ther 44 doi #.#/S#-# 44 oesophageal adenocarcinoma 44 EORTC QLQ C# 44 pharmacodynamics PD 44 Randomized Evaluation 44 coexistent 44 Immunohistochemistry 44 amnestic MCI 44 p# biomarker 44 PDSS 44 spontaneous preterm delivery 44 J Pediatr 44 del 5q 44 recurrent GBM 44 Coronary Angiography 44 transrectal ultrasound 44 fludarabine cyclophosphamide 44 radical retropubic prostatectomy 44 Mantoux test 44 hypogonadal 44 neoplasias 44 lymphoproliferative disorders 44 microg 44 mucinous 44 CPT coding 44 protein tyrosine phosphatase 44 HSCR 44 Computed Tomographic 44 Pain Intensity 44 laparoscopic radical nephrectomy 44 undergoing radical cystectomy 44 Topical corticosteroids 44 Symptom severity 44 Am J Epidemiol 44 J Foot Ankle 44 mediastinal lymph nodes 44 non CF bronchiectasis 44 azacytidine 44 MetS 44 pharmacologic therapies 44 underlying pathophysiology 44 pharmacodynamic parameters 44 AGHD 44 nosocomial infection 44 Tomographic 44 tele ICU 44 physiologic parameters 44 Likert scale 44 functional mitral regurgitation 44 Rating Scale UPDRS 44 juvenile idiopathic arthritis 44 mesangial 44 idiopathic membranous nephropathy 44 REDCOP 44 localized prostate 44 universal salt iodisation 44 differential gene expression 44 Stenting Trial 44 EchoCRT 44 HAM D 44 multimodality therapy 44 sotalol 44 tolterodine ER 44 prehospital setting 44 Papillary 44 MVA HPV IL2 44 Myelosuppression 44 Haemodialysis 44 intracranial stenosis 44 Candida infection 44 sentinel surveillance 44 mechanically ventilated 44 Environ Health Perspect 44 adjuvant hormonal therapy 44 nonfasting triglyceride levels 44 relapsing multiple sclerosis 44 IDET 44 polyposis 44 pmol liter 44 Cognitive behavioral 44 tHcy 44 QOPI 44 prostate carcinogenesis 44 intensive lipid lowering 44 PANSS 44 classes #A# #A# 44 invasive prenatal 44 chi squared 44 CRQ 44 axillary nodes 44 Breast conserving 44 nonepileptic seizures 44 conditional logistic regression 44 pulmonary artery catheter 44 Myelodysplastic Syndrome 44 AKUH